Market Cap | ₹64,386Cr |
ROE | 33.41% |
P/E Ratio(TTM) | 44.33 |
EPS(TTM) | 683.43 |
P/B Ratio | 15.21 |
Dividend Yield | 1.57% |
Industry P/E | 41.14 |
Book Value | 1992.07 |
Debt to Equity | 0.05 |
Face Value | 10 |
Parent Organisation | Abbott India Limited |
Managing Director | Mr. Vivek Kamath |
NSE Symbol | ABBOTINDIA |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
GlaxoSmithKline Pharmaceuticals | NA (0.00%) | 48.81 | ||
Pfizer | NA (0.00%) | 28.91 | ||
Astrazeneca Pharma India | NA (0.00%) | 121.87 | ||
Sanofi Consumer Healthcare India | NA (0.00%) | 59.53 |